University of Maryland Greenebaum Cancer Center — Baltimore, Maryland

University of Maryland Greenebaum Cancer Center is a clinical research site located in Baltimore, Maryland, United States 21201-1595.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Maryland Greenebaum Cancer Center has participated in 72 clinical trials with 16 currently active.

Therapeutic areas: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia.

Sponsors: National Cancer Institute (NCI), Celldex Therapeutics, Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Maryland Greenebaum Cancer Center?

University of Maryland Greenebaum Cancer Center has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Maryland Greenebaum Cancer Center conducted?

University of Maryland Greenebaum Cancer Center has 72 clinical trials on record, with 16 currently active. Their work covers Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia.

Is University of Maryland Greenebaum Cancer Center accredited by Crixeo Health?

University of Maryland Greenebaum Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Maryland Greenebaum Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.